FDA Inspection 1277120 - Mark J. Hamblin, MD - July 18, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Mark J. Hamblin, MD, with an inspection on July 18, 2025, issued by the Kansas City District Office, covering human drugs.

Company: Mark J. Hamblin, MD
Inspection Date: July 18, 2025
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · 1a106fd2-3ec8-4fd5-b1db-aa41ce8a5d5c